Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 3
This trial is looking at durvalumab and tremelimumab after having surgery to remove kidney cancer.
Recruitment start: 19 July 2018
Recruitment end: 30 June 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor James Larkin
Cancer Research UK
University College London (UCL)
Kidney Cancer UK
Last reviewed: 3 September 2023
CRUK internal database number: 16962
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
